TNF and inflammatory bowel disease: Out of a total of 5000 patients with IBD and COVID infection, only 72 patients were treated with tofacitinib according to the Surveillance Epidemiology of Coronavirus Under Research Exclusion- database in contrast to 1581 patients treated with an anti-TNF.